| 영문 | hypertensive heart disease | 한글 | 고혈압심장병 |
|---|---|---|---|
| 설명 | 고혈압에 의해서 생기는 심장병. 고혈압심장병이라는 진단을 붙이기 위해서는 최소한 다음과 같은 조건이 부합되어야 하는데, 첫째 심장혈관계에 심장병을 유발할 수 있을 만한 다른 병변이 없이 좌심실 비대가 있어야 하며, 둘째 고혈압을 앓았다는 병력이 있어야 한다. 주로 고혈압에 의한 심장병은 초기에는 좌심실이 비후라는 것으로 특징되어진다. 즉 혈압이 높으므로 혈액을 순환시키기 위해서는 그만큼 심장의 혈액을 보내는 힘이 좋아야 한다. 그 힘을 얻기위해서는 심근의 비후가 필요로 하여 좌심실 근육의 비후가 생긴다. 그리고 고혈압이 지속이 될 경우에는 결국 심장이 제 구실을 하지 못하고 펌프로서의 기능을 잃어버리게 되어 심장기능상실에 빠지게 된다. |
||
| KW change | Keith Wagener change |
|---|---|
| HCVD | Hypertensive Cardio-Vascular Disease; 고혈압 심장성 혈관 질환 |
| IABP | Intra-Aortic Balloon Pump(Plasty) - Ix 1. Low Output Synd... |
| ASHCVD | atherosclerotic hypertensive cardiovascular disease |
| BH | base hospital; benzalkonium and heparin; bill of health; birth history; Bishop-Harman [instruments];... |
| SHRSP | Spontaneously hypertensive rats and stroke-prone spontaneously hypertensive rats |
|---|---|
| CGI-C | Clinical Global Impression of Change |
| FAC | Fractional area change |
| HSC | Health System Change |
| MCD | Minimal change disease |
| chronic hypertensive disease | The chronic accumulative effects of long-standing high blood pressure on such vital organs as the heart, kidney, and brain. (05 Mar 2000) |
|---|---|
| hypertensive | 1. Marked by an increased blood pressure. 2. Denoting a person suffering from high blood pressure. (05 Mar 2000) |
| hypertensive angiopathy | A condition of turkeys of unknown aetiology, associated with sudden death in rapidly growing male birds. (05 Mar 2000) |
| hypertensive arteriopathy | Arterial degeneration resulting from hypertension. (05 Mar 2000) |
| hypertensive arteriosclerosis | Progressive increase in muscle and elastic tissue of arterial walls, resulting from hypertension; in longstanding hypertension, elastic tissue forms numerous concentric layers in the intima and there is replacement of muscle by collagen fibres and hyaline thickening of the intima of arterioles; such changes can develop with increasing age in the absence of hypertension and may then be referred to as senile arteriosclerosis. (05 Mar 2000) |
| hypertensive encephalopathy | A metabolic encephalopathy caused by diffuse cerebral oedema; follows an abrupt elevation of blood pressure in a long-term hypertensive patient. (05 Mar 2000) |
| hypertensive retinopathy | A retinal condition occurring in accelerated vascular hypertension, marked by arteriolar constriction, flame-shaped haemorrhages, cotton-wool patches, star-figure oedema at the macula, and papilledema. (05 Mar 2000) |
| Armanni-Ebstein change | Glycogen vacuolization of the loops of Henle, seen in diabetics before the introduction of insulin. Synonym: Armanni-Ebstein change. (05 Mar 2000) |
| Baggenstoss change | Distention of pancreatic acini by proteinaceous secretion, seen in dehydration. (05 Mar 2000) |
| change | An alteration; in pathology, structural alteration of which the cause and significance is uncertain. Synonym: shift. (05 Mar 2000) |
| change of life | Colloquialism for menopause, climacteric. (05 Mar 2000) |
| chemical change | A process in which one or more substances are changed into one or more different substances. (09 Oct 1997) |
| minimal-change disease | <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure. This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness. It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown. Risk factors include a history for a immune disorder, recent immunisation or a bee sting. Diagnosis is made by renal biopsy. Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented. Synonym: lipoid nephrosis (27 Sep 1997) |
| minimal-change nephrotic syndrome | <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure. This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness. It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown. Risk factors include a history for a immune disorder, recent immunisation or a bee sting. Diagnosis is made by renal biopsy. Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented. Synonym: lipoid nephrosis (27 Sep 1997) |
| conformational change | <cell biology> Alteration in the shape usually the tertiary structure of a protein as a result of alteration in the environment pH, temperature, ionic strength) or the binding of a ligand (to a receptor) or binding of substrate (to an enzyme). (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|